TSHA
Taysha Gene Therapies, Inc. Common StockstockNASDAQ
Market OpenNov 19, 2026 9:34:01 AM EST
4.07USD+2.005%(+0.08)128,388
TSHA Financials
In Q3 FY 2026 (ended ), Taysha Gene Therapies, Inc. Common Stock (TSHA) reported revenue of $0, net income of −$39.13M, operating cash flow of −$32.91M, and assets of $435.03M (filed ).
Loading financial statements…